|
1
|
Friedman SL: Mechanisms of disease:
Mechanisms of hepatic fibrosis and therapeutic implications. Nat
Clin Pract Gastroenterol Hepatol. 1:98–105. 2004. View Article : Google Scholar
|
|
2
|
Bataller R and Brenner DA: Liver fibrosis.
J Clin Invest. 115:209–218. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Poli G: Pathogenesis of liver fibrosis:
role of oxidative stress. Mol Aspects Med. 21:49–98. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Afdhal NH: The natural history of
hepatitis C. Semin Liver Dis. 24(Suppl 2): 3–8. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McMahon BJ: The natural history of chronic
hepatitis B virus infection. Semin Liver Dis. 24(Suppl 1): 17–21.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lavanchy D: Hepatitis B virus
epidemiology, disease burden, treatment, and current and emerging
prevention and control measures. J Viral Hepat. 11:97–107. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brenner DA: Molecular pathogenesis of
liver fibrosis. Trans Am Clin Climatol Assoc. 120:361–368.
2009.PubMed/NCBI
|
|
8
|
Rosenbloom J, Castro SV and Jimenez SA:
Narrative review: fibrotic diseases: cellular and molecular
mechanisms and novel therapies. Ann Intern Med. 152:159–166. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lissoos TW, Beno DW and Davis BH: Hepatic
fibrogenesis and its modulation by growth factors. J Pediatr
Gastroenterol Nutr. 15:225–231. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Friedman SL: Seminars in medicine of the
Beth Israel Hospital, Boston. The cellular basis of hepatic
fibrosis Mechanisms and treatment strategies. N Engl J Med.
328:1828–1835. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mavier P and Mallat A: Perspectives in the
treatment of liver fibrosis. J Hepatol. 22(Suppl): 111–115.
1995.PubMed/NCBI
|
|
12
|
Iredale J: Defining therapeutic targets
for liver fibrosis: exploiting the biology of inflammation and
repair. Pharmacol Res. 58:129–136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamaura K, Takahashi KG and Suzuki T:
Identification and tissue expression analysis of C-type lectin and
galectin in the Pacific oyster, Crassostrea gigas. Comp Biochem
Physiol B Biochem Mol Biol. 149:168–175. 2008. View Article : Google Scholar
|
|
14
|
Fishery and Aquaculture Statistics 2007.
Food and Agriculture Organization of the United Nations; Rome: pp.
542009
|
|
15
|
Gaté L, Schultz M, Walsh E, et al: Impact
of dietary supplement of Crassostrea gigas extract (JCOE) on
glutathione levels and glutathione S-transferase activity in rat
tissues. In Vivo. 12:299–303. 1998.PubMed/NCBI
|
|
16
|
Gaté L, Paul J, Ba GN, Tew KD and Tapiero
H: Oxidative stress induced in pathologies: the role of
antioxidants. Biomed Pharmacother. 53:169–180. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gressner OA and Gressner AM: Connective
tissue growth factor: a fibrogenic master switch in fibrotic liver
diseases. Liver Int. 28:1065–1079. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tamatani T, Kobayashi H, Tezuka K, et al:
Establishment of the enzyme-linked immunosorbent assay for
connective tissue growth factor (CTGF) and its detection in the
sera of biliary atresia. Biochem Biophys Res Commun. 251:748–752.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang D, Wang NY, Yang CB, et al: The
clinical value of serum connective tissue growth factor in the
assessment of liver fibrosis. Dig Dis Sci. 55:767–774. 2010.
View Article : Google Scholar
|
|
20
|
Guo-Qiu W, Nai-Feng L, Xiao-Bo V, et al:
The level of connective tissue growth factor in sera of patients
with hepatitis B virus strongly correlates with stage of hepatic
fibrosis. Viral Immunol. 23:71–78. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Piao RL, Brigstock DR, Zhu J, Zhang ML and
Gao RP: Clinical significance of connective tissue growth factor in
hepatitis B virus-induced hepatic fibrosis. World J Gastroenterol.
18:2280–2286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dessein A, Arnaud V, He H, et al: Genetic
analysis of human predisposition to hepatosplenic disease caused by
schistosomes reveals the crucial role of connective tissue growth
factor in rapid progression to severe hepatic fibrosis. Pathol Biol
(Paris). 61:3–10. 2013. View Article : Google Scholar
|
|
23
|
Torre F, Bellis L, Delfino A, et al:
Peripheral blood serum markers for apoptosis and liver fibrosis:
are they trustworthy indicators of liver realness? Dig Liver Dis.
40:441–445. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Papa S, Zazzeroni F, Bubici C, et al:
Gadd45 beta mediates the NF-kappa B suppression of JNK signalling
by targeting MKK7/JNKK2. Nat Cell Biol. 6:146–153. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fu M, Zhang J, Zhu X, et al: Peroxisome
proliferator-activated receptor gamma inhibits transforming growth
factor beta-induced connective tissue growth factor expression in
human aortic smooth muscle cells by interfering with Smad3. J Biol
Chem. 276:45888–45894. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen A and Zheng S: Curcumin inhibits
connective tissue growth factor gene expression in activated
hepatic stellate cells in vitro by blocking NF-kappaB and ERK
signalling. Br J Pharmacol. 153:557–567. 2008. View Article : Google Scholar
|
|
27
|
Sun H, Che QM, Zhao X and Pu XP:
Antifibrotic effects of chronic baicalein administration in a
CCl4 liver fibrosis model in rats. Eur J Pharmacol.
631:53–60. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Erman F, Balkan J, Cevikbaş U, Koçak-Toker
N and Uysal M: Betaine or taurine administration prevents fibrosis
and lipid peroxidation induced by rat liver by ethanol plus carbon
tetrachloride intoxication. Amino Acids. 27:199–205. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin X, Zhang S, Huang Q, et al: Protective
effect of Fufang-Liu-Yue-Qing, a traditional Chinese herbal
formula, on CCl4 induced liver fibrosis in rats. J
Ethnopharmacol. 142:548–556. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Basu S: Carbon tetrachloride-induced lipid
peroxidation: eicosanoid formation and their regulation by
antioxidant nutrients. Toxicology. 189:113–127. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Oh WY, Pyo S, Lee KR, et al: Effect of
Holotrichia diomphalia larvae on liver fibrosis and hepatotoxicity
in rats. J Ethnopharmacol. 87:175–180. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dendooven A, Gerritsen KG, Nguyen TQ, Kok
RJ and Goldschmeding R: Connective tissue growth factor (CTGF/CCN2)
ELISA: a novel tool for monitoring fibrosis. Biomarkers.
16:289–301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Abou-Shady M, Friess H, Zimmermann A, et
al: Connective tissue growth factor in human liver cirrhosis.
Liver. 20:296–304. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hora C, Negro F, Leandro G, et al:
Connective tissue growth factor, steatosis and fibrosis in patients
with chronic hepatitis C. Liver Int. 28:370–376. 2008. View Article : Google Scholar
|
|
35
|
Williams EJ, Gaça MD, Brigstock DR, Arthur
MJ and Benyon RC: Increased expression of connective tissue growth
factor in fibrotic human liver and in activated hepatic stellate
cells. J Hepatol. 32:754–761. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Friedman SL: Molecular regulation of
hepatic fibrosis, an integrated cellular response to tissue injury.
J Biol Chem. 275:2247–2250. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu Y, Wen XM, Lui EL, et al: Therapeutic
targeting of the PDGF and TGF-beta-signaling pathways in hepatic
stellate cells by PTK787/ZK22258. Lab Invest. 89:1152–1160. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gressner OA, Lahme B, Demirci I, Gressner
AM and Weiskirchen R: Differential effects of TGF-beta on
connective tissue growth factor (CTGF/CCN2) expression in hepatic
stellate cells and hepatocytes. J Hepatol. 47:699–710. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hernandez-Gea V and Friedman SL:
Pathogenesis of liver fibrosis. Annu Rev Pathol. 6:425–456. 2011.
View Article : Google Scholar
|
|
40
|
Biernacka A, Dobaczewski M and
Frangogiannis NG: TGF-β signaling in fibrosis. Growth Factors.
29:196–202. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nakamura T, Sakata R, Ueno T, Sata M and
Ueno H: Inhibition of transforming growth factor beta prevents
progression of liver fibrosis and enhances hepatocyte regeneration
in dimethylnitrosamine-treated rats. Hepatology. 32:247–255. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Povero D, Busletta C, Novo E, et al: Liver
fibrosis: a dynamic and potentially reversible process. Histol
Histopathol. 25:1075–1091. 2010.PubMed/NCBI
|
|
43
|
Tache D, Bogdan F, Pisoschi C, et al:
Evidence for the involvement of TGF-β1-CTGF axis in liver
fibrogenesis secondary to hepatic viral infection. Rom J Morphol
Embryol. 52(Suppl): 409–412. 2011.
|
|
44
|
Weng HL, Ciuclan L, Liu Y, et al:
Profibrogenic transforming growth factor-beta/activin receptor-like
kinase 5 signaling via connective tissue growth factor expression
in hepatocytes. Hepatology. 46:1257–1270. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kovalenko E, Tacke F, Gressner OA, et al:
Validation of connective tissue growth factor (CTGF/CCN2) and its
gene polymorphisms as noninvasive biomarkers for the assessment of
liver fibrosis. J Viral Hepat. 16:612–620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Igarashi A, Okochi H, Bradham DM and
Grotendorst GR: Regulation of connective tissue growth factor gene
expression in human skin fibroblasts and during wound repair. Mol
Biol Cell. 4:637–645. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Fox ES, Kim JC and Tracy TF: NF-kappaB
activation and modulation in hepatic macrophages during cholestatic
injury. J Surg Res. 72:129–134. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Demirbilek S, Akin M, Gürünlüoğlu K, et
al: The NF-kappaB inhibitors attenuate hepatic injury in bile duct
ligated rats. Pediatr Surg Int. 22:655–663. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Rippe RA, Schrum LW, Stefanovic B,
Solís-Herruzo JA and Brenner DA: NF-kappaB inhibits expression of
the alpha1(I) collagen gene. DNA Cell Biol. 18:751–761. 1999.
View Article : Google Scholar : PubMed/NCBI
|
